BiotechTube
Home/Syntiron/Lisa Herron-Olson, Ph.D.
LH

Lisa Herron-Olson, Ph.D.

Managing Director

Syntiron

Therapeutic Areas

Infectious DiseasesAntimicrobial Resistance

Syntiron Pipeline

DrugIndicationPhase
ALLOY UTI VaccineUrinary Tract Infection PreventionPre-clinical
Maternal VaccineNeonatal Sepsis PreventionPre-clinical
Platform PipelinePneumonia, Sepsis, Severe Invasive Infection, Skin InfectionDiscovery/Pre-clinical

Leadership Team at Syntiron

LR
Leah Randles, Ph.D.
Senior Scientific Director
View full Syntiron profile